Form D · Pharmaceuticals
Dosentrx Ltd.
Modiin Maccabim Reut, L3 · CIK 0002121365
Offering snapshot reported Mar 19, 2026 · SEC filing
- Reported sold
- $1.78M Offering amount: $6M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Feb 18, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 19, 2026 | Initial | $1,780,000 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $390K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-577060
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Cedar Point Capital LLC | 145116 |
Source: Form D, filed Mar 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Beck | Director |
| Liron Levi Gabay | Executive |
| Gerald Lieberman | Director |
| Alan Paz | Director, Executive |
| Jon Roberts | Director |
| Frank Sheehy | Director |
| Mark Summers | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1 Hamaayan St
Modiin Maccabim Reut, L3, 7177874
Phone: 972 52-2890796
Modiin Maccabim Reut, L3, 7177874
Phone: 972 52-2890796